Christopher Raymond's
Stock Forecasts

Christopher Raymond win rate

14.29%

4/28 win trades

Christopher Raymond is a Wall Street stock analyst with a 14.29% win rate, who was right in predicting 4 out of 28 price targets. Most frequently covered stocks by this analyst are ABBV, REGN, BIIB and BMRN. He has published 0 price targets in the last month and 3 last year.

Price targets by Christopher Raymond

Company name & ticker Publish date Price target Price when posted Source Historical targets
BIIB logo
Biogen Inc.
BIIB
 10 months ago $315 127.02% upside $181.18 StreetInsider
AMGN logo
Amgen Inc.
AMGN
 12 months ago $344 15.66% upside $330.92 StreetInsider Previous targets (0)
NUVL logo
Nuvalent, Inc.
NUVL
 12 months ago $100 33.33% upside $87.45 StreetInsider Previous targets (0)
BMRN logo
BioMarin Pharmaceutical Inc.
BMRN
 about 1 year ago $122 114.03% upside $86.74 StreetInsider
ABBV logo
AbbVie Inc.
ABBV
 about 1 year ago $209 1.11% upside $197.35 StreetInsider
REGN logo
Regeneron Pharmaceuticals, Inc.
REGN
 about 1 year ago $1,242 116.07% upside $1,187.66 TheFly
TYRA logo
Tyra Biosciences, Inc.
TYRA
 about 1 year ago $33 226.73% upside $21.57 StreetInsider Previous targets (0)
ALXO logo
ALX Oncology Holdings Inc.
ALXO
 over 1 year ago $21 2323.54% upside $9.1 StreetInsider Previous targets (0)
RARE logo
Ultragenyx Pharmaceutical Inc.
RARE
 over 1 year ago $135 351.50% upside $38.65 StreetInsider
ARDX logo
Ardelyx, Inc.
ARDX
 over 1 year ago $15 156.84% upside $7.2 TheFly Previous targets (0)
VRTX logo
Vertex Pharmaceuticals Incorporated
VRTX
 over 1 year ago $456 16.77% upside $413.42 StreetInsider Previous targets (0)
BPMC logo
Blueprint Medicines Corporation
BPMC
 over 1 year ago $104 -19.66% downside $106.29 StreetInsider Previous targets (0)
DCPH logo
Deciphera Pharmaceuticals, Inc.
DCPH
 over 1 year ago $25 N/A downside $25.29 StreetInsider Previous targets (0)
TSHA logo
Taysha Gene Therapies, Inc.
TSHA
 over 1 year ago $9 220.28% upside $2.68 StreetInsider Previous targets (0)
QTTB logo
Q32 Bio Inc.
QTTB
 over 1 year ago $45 2372.52% upside $18 TheFly Previous targets (0)
SLDB logo
Solid Biosciences Inc.
SLDB
 over 1 year ago $20 241.88% upside $12.23 StreetInsider Previous targets (0)

Other analysts covering same stocks

Andrew Galler
Wolfe Research
100%
win rate
Covering:
Daniel Busby
RBC Capital
100%
win rate
Covering:
Luisa Hector
Berenberg Bank
100%
win rate
Covering:
Geoff Porges
Leerink Partners
100%
win rate
Covering:
Tiago Fauth
Credit Suisse
85.71%
win rate
Covering:
AMGNAPLSBMRNFMTXRXDXUTHR …
Tim Anderson
Wolfe Research
83.33%
win rate
Covering:
Navin Jacob
UBS
75%
win rate
Covering:
Andrew Baum
Citigroup
66.67%
win rate
Covering:
Gary Nachman
BMO Capital
66.67%
win rate
Covering:
Steve Scala
Cowen & Co.
66.67%
win rate
Covering:
Joshua Schimmer
Evercore ISI
66.67%
win rate
Covering:
Kennen MacKay
RBC Capital
62.5%
win rate
Covering:
ALXNAMGNEXELNUVBPRTAREGN …
Esther Rajavelu
UBS
62.5%
win rate
Covering:
ALNYDNLIIONSJAZZRARERCKT …
Colin Bristow
UBS
61.54%
win rate
Covering:
ALXNALXOAMGNBIIBGILDIMVT …
Olivia Brayer
Cantor Fitzgerald
60%
win rate
Covering:
Steve Chesney
Atlantic Equities
60%
win rate
Covering:
Laura Chico
Wedbush
57.14%
win rate
Covering:
APLSARDXBIIBLRMRNBIXPHVS …
John Newman
Canaccord Genuity
57.14%
win rate
Covering:
ACLXALLOBLUEGBTMRUSREGN …
Matthew Harrison
Morgan Stanley
55.26%
win rate
Covering:
ADAGADCTALXNBGNEBIIBBMRN …
Carter Gould
Barclays
53.57%
win rate
Covering:
ABBVAMGNBIIBBMYBRNSCYTK …
Tyler Van Buren
Cowen & Co.
50%
win rate
Covering: